USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Guangdong Raynovent Biotech Co., Ltd.

USPTO PatentsView assignee record - 13 granted patents across 7 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, Guangdong ranks #21,201 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 7 technology areas.

#21,201
of 49,997 US assignees by volume
41st percentile
by Innovation Score (32.3/100)
16.6
avg claims per patent
+350%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21201 · Foreign Corporation #21,201 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 13 grants
  • MID-PACK #21,201/49,997
  • PHOTO-FINISH Greater Shine
  • CPC-NARROW A61P · 7 areas
  • INNOV-THIN 32.3/100
  • CLAIMS-RICH 16.6 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +350% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Greater Shine Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Guangdong’s 32.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Guangdong

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Guangdong's Innovation Score is 32.3/100 (41st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Guangdong?

Each dot is one of Guangdong’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Guangdong’s own 16.6 claims/patent is ABOVE the 6.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Guangdong vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 12.912.91313.1 05101520 Granted patents (volume) Avg claims / patent Greater Shine Limited - 13, 16.92Greater ShineGreen KEY Technologies, Inc. - 13, 16.46Green KEYGrowlerwerks, Inc. - 13, 4.77GrowlerwerksGSI Outdoors, Inc. - 13, 6.85GSI OutdoorsGuangdong Xinbao Electrical Appliances Holdings Co., Ltd. - 13, 7.54Guangdong Xinbao…Guangzhou Cellprotek Pharmaceutical Co., Ltd - 13, 6.62Guangzhou Cellpro…Guangzhou Huiyue Technology Development Co., Ltd. - 13, 1Guangzhou Huiyue…Guilin University OF Technology - 13, 7.92Guilin University…Guangdong Raynovent Biotech Co., Ltd. - 13, 16.62Guangdong Raynove…
Guangdong vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Guangdong's grants concentrate

Guangdong Raynovent Biotech Co., Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 92.3% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (4 grants) versus a trough of 1 in 2021. By volume, Guangdong sits between Greater Shine Limited and Guilin University OF Technology.

Guangdong's three-year grant acceleration

Guangdong Raynovent Biotech Co., Ltd. shows 4 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Guangdong's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Guangdong holds 13 patents at rank #21,178, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Guangdong

By rank, the assignees closest to #21,178 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Guangdong's primary technology class.

Guangdong's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 41st percentile higher than 41% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 201920202021202220232025 2
USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Guangdong Raynovent Biotech Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 2 15.4%
2020 4 30.8%
2021 1 7.7%
2022 3 23.1%
2023 1 7.7%
2025partial year 2 15.4%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Guangdong Raynovent Biotech Co., Ltd.'s patent record in context - here's where to go next.

  • Guangdong Raynovent Biotech Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 92.3% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #21,201 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Guangdong Raynovent Biotech Co., Ltd. against Greater Shine Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 32.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.